Alum
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Alum, covering 2025-09-25 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Trial to Evaluate the Safety and Immunogenicity of Priming Regimens of 426c.Mod.Core-C4b and Optional Boost Regimen With HIV Trimer BG505 SOSIP.GT1.1 gp140, Both Adjuvanted With 3M-052-AF + Alum in Healthy, Adult Participants Without HIV [Phase 1]